STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drug combo slow prostate cancer spread before surgery?
Disease control CompletedThis study looked at men with prostate cancer that had spread or might spread to lymph nodes. Before surgery, some men got standard hormone therapy alone, while others got hormone therapy plus a drug called axitinib. The goal was to see if adding axitinib could better control the…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New combo therapy shows promise for Hard-to-Treat prostate cancer
Disease control CompletedThis study tested whether adding precise, high-dose radiation (SBRT) to the drug apalutamide helps control prostate cancer that no longer responds to standard hormone therapy and has spread to a few spots. Twenty-six men with castration-resistant prostate cancer participated. The…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 14, 2026 12:03 UTC